iShares U.S. Pharmaceuticals ETF (IHE) Stock Overview
Explore iShares U.S. Pharmaceuticals ETF’s financial performance, market position, analyst ratings, and future outlook.
iShares U.S. Pharmaceuticals ETF (IHE)
Key Financials
Key Financials
Market Cap
1.2B
P/E Ratio
N/A
EPS (TTM)
$3.57
ROE
0.00%
IHE Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of iShares U.S. Pharmaceuticals ETF (AMEX: IHE) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, iShares U.S. Pharmaceuticals ETF's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IHE on the AMEX shows an RSI of 64.54, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $109.56 for the AMEX listing.
Key metrics behind iShares U.S. Pharmaceuticals ETF's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IHE on the AMEX.